RNLX (renalytix.com) Future Price to Earnings

Brandmark of Renalytix plc (RNLX)

How does cloud data outsourcing impact the valuation of Renalytix Plc (RNLX)? The company's forward P/E trend clearly provides the answer, where 0.00 reflects the most recent value of the metric. Geopolitical fractures and sanctions are currently limiting the expansion of diagnostic systems, while low insurance coverage and an acute liquidity shortage create serious financial risks for the business.

RNLX - Renalytix PLC Market Cap to Projected Earnings over the range 07/04/2022 - 10/19/2024

Renalytix (RNLX) - metric breakdowns and financial figures

- current price and projected stock value:
- business market valuation indicators:
Analysis of all company metrics:Renalytix RNLX
Signature product of renalytix.com

The selection of defensive assets is based on a business's ability to generate sustainable cash flow, which for Renalytix Plc (RNLX) is ensured by the integration of the KidneyIntelX AI platform into global nephrology practice. The company's current forward P/E, equal to 0.00, is calculated as the ratio of the market share price to the projected annual earnings, reflecting market expectations for the scaling of this diagnostic ecosystem.